Multi-Omics Data Fusion for Cancer Molecular Subtyping Using Sparse Canonical Correlation Analysis

Abstract

It is now clear that major malignancies are heterogeneous diseases associated with diverse molecular properties and clinical outcomes, posing a great challenge for more individualized therapy. In the last decade, cancer molecular subtyping studies were mostly based on transcriptomic profiles, ignoring heterogeneity at other (epi-)genetic levels of gene regulation. Integrating multiple types of (epi)genomic data generates a more comprehensive landscape of biological processes, providing an opportunity to better dissect cancer heterogeneity. Here, we propose sparse canonical correlation analysis for cancer classification (SCCA-CC), which projects each type of single-omics data onto a unified space for data fusion, followed by clustering and classification analysis. Without loss of generality, as case studies, we integrated two types of omics data, mRNA and miRNA profiles, for molecular classification of ovarian cancer (n = 462), and breast cancer (n = 451). The two types of omics data were projected onto a unified space using SCCA, followed by data fusion to identify cancer subtypes. The subtypes we identified recapitulated subtypes previously recognized by other groups (all P- values < 0.001), but display more significant clinical associations. Especially in ovarian cancer, the four subtypes we identified were significantly associated with overall survival, while the taxonomy previously established by TCGA did not (P- values: 0.039 vs. 0.12). The multi-omics classifiers we established can not only classify individual types of data but also demonstrated higher accuracies on the fused data. Compared with iCluster, SCCA-CC demonstrated its superiority by identifying subtypes of higher coherence, clinical relevance, and time efficiency. In conclusion, we developed an integrated bioinformatic framework SCCA-CC for cancer molecular subtyping. Using two case studies in breast and ovarian cancer, we demonstrated its effectiveness in identifying biologically meaningful and clinically relevant subtypes. SCCA-CC presented a unique advantage in its ability to classify both single-omics data and multi-omics data, which significantly extends the applicability to various data types, and making more efficient use of published omics resources.

Explore the prognostic characteristics of immunogenic cell death- related genes in colon carcinoma based on multi-constraint canonical correlation analysis

“…Lin et al proposed a cancer classification sparse canonical correlation analysis (SCCA-CC), in which each type of univariate data is projected into a unified space for data fusion and then clustering and classification analysis are performed. The findings demonstrate that SCCA-CC has distinct advantages in classifying multi-omics data [12].…”

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration

“…Next, they took the average of these matrices as a fused matrix and applied it to a spectral clustering algorithm for cancer subtype discovery. Qi et al (2021) proposed a sparse canonical correlation analysis for cancer classification where each single omics data is first projected into a unified space and then integrated by weighted averaging strategy. Multiple kernel learning (MKL) is an extension to kernel support vector machine (SVM) which has received great popularity in the omics integration field ( Gönen and Alpaydin, 2011 ).…”

Integration of Multi-omics Data for the Classification of Glioma Types and Identification of Novel Biomarkers

“…Recent advances in high-throughput technologies, particularly next-generation sequencing, have been allowing the extraction of an increasing quantity of biological data, which is not limited to one but instead includes multiple omics modalities collected from the same individuals. The joint integrative study of the different but linked layers of genetic regulation (e.g., genome, epigenome, transcriptome, proteome, metabolome) offers an opportunity to build a more comprehensive landscape of biological systems and further enhance the molecular understanding of disease, where research has relied mostly on single-omics data [9].…”